Opus GeneticsIRD
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 38 institutions reported holding Opus Genetics Inc. (IRD) in their 13F filings, up 1 from Q2 2024. 6 opened new positions and 5 sold out. The largest holders were Vanguard Group Inc. ($1.3M), Geode Capital Management, LLC ($357K) and Bridgeway Capital Management, LLC ($217K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Opus Genetics Inc.
- Filed as
- OCUPHIRE PHARMA INC (Q3 2024)
- CUSIP
- 67577R102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $102K |
| Exits | 5 | $409K |
All 13F filers, Q2 2024 → Q3 2024: 193,272 shares bought and 360,165 shares sold, net −166,893 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 38 holders
| Vanguard Group Inc. | 0.00% | No change | 992,200 | $1.3M |
| Geode Capital Management, LLC | 0.00% | Add +2.4% | 272,281 | $357K |
| Bridgeway Capital Management, LLC | 0.00% | Add +1.2% | 165,751 | $217K |
| Richmond Brothers, Inc. | 0.13% | Reduce -18.6% | 155,620 | $204K |
| BlackRock, Inc. | 0.00% | — | 109,323 | $143K |
| Knoll Capital Management, LLC | 0.06% | No change | 100,000 | $131K |
| Citadel Advisors | 0.00% | Add +515.8% | 86,819 | $114K |
| Renaissance Technologies | 0.00% | Add +69.3% | 70,609 | $92K |
| State Street Corp. | 0.00% | No change | 70,473 | $92K |
| Morgan Stanley | 0.00% | Reduce -0.0% | 56,096 | $73K |
| Susquehanna International Group, LLP | 0.00% | Add +6.8% | 49,755 | $65K |
| Kestra Private Wealth Services, LLC | 0.00% | No change | 42,341 | $55K |
| Empowered Funds, LLC | 0.00% | Add +5.1% | 41,315 | $54K |
| Blair William & Co. | 0.00% | No change | 33,267 | $44K |
| Diametric Capital, LP | 0.02% | Reduce -12.6% | 33,251 | $44K |
| Trust Co. of Toledo NA | 0.01% | No change | 30,963 | $41K |
| Comerica Bank | 0.00% | No change | 30,000 | $39K |
| XTX Topco Ltd | 0.00% | New | 27,892 | $37K |
| Northern Trust Corp. | 0.00% | No change | 27,267 | $36K |
| Virtu Financial LLC | 0.00% | New | 23,728 | $31K |
| Captrust Financial Advisors | 0.00% | No change | 18,000 | $24K |
| Bedel Financial Consulting, Inc. | 0.00% | No change | 15,000 | $20K |
| Osaic Holdings, Inc. | 0.00% | Reduce -35.5% | 13,905 | $18K |
| Stokes Family Office, LLC | 0.00% | No change | 12,120 | $16K |
| Prelude Capital Management, LLC | 0.00% | Reduce -12.6% | 12,110 | $16K |
| Raymond James & Associates | 0.00% | New | 11,758 | $15K |
| Commonwealth Equity Services, LLC | 0.00% | New | 11,739 | $15K |
| UBS Group AG | 0.00% | Reduce -63.8% | 5,687 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -6.0% | 3,377 | $4K |
| Wells Fargo & Company | 0.00% | No change | 2,789 | $4K |
| National Bank of Canada | 0.00% | Reduce -83.2% | 2,014 | $3K |
| Barclays PLC | 0.00% | New | 1,900 | $2K |
| CarsonAllaria Wealth Management, Ltd. | 0.00% | No change | 1,000 | $1K |
| Eastern Bank | 0.00% | New | 1,000 | $1K |
| Bank of America Corp. | 0.00% | Reduce -5.2% | 202 | $265 |
| Harbour Investments, Inc. | 0.00% | No change | 40 | $52 |
| FSA Wealth Management LLC | 0.00% | — | 5 | $7 |
| Royal Bank of Canada | 0.00% | Reduce -100.0% | 5 | $0 |
"% of holder's portfolio" is IRD's weight in each manager's 13F, not the share of Opus Genetics Inc. the manager owns.